BIOMAT Database Logo BIOMAT Database Logo

Management of vasoplegia after cardiopulmonary bypass: role of prostaglandin inhibition. 2007

John G T Augoustides

UI MeSH Term Description Entries
D011448 Prostaglandin Antagonists Compounds that inhibit the action of prostaglandins. Prostaglandin Inhibitors,Antagonists, Prostaglandin,Inhibitors, Prostaglandin,Prostaglandin Antagonist,Prostaglandin Inhibitor,Antagonist, Prostaglandin,Inhibitor, Prostaglandin
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012769 Shock A pathological condition manifested by failure to perfuse or oxygenate vital organs. Circulatory Collapse,Circulatory Failure,Hypovolemic Shock,Collapse, Circulatory,Failure, Circulatory,Shock, Hypovolemic
D014652 Vascular Diseases Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body. Disease, Vascular,Diseases, Vascular,Vascular Disease

Related Publications

John G T Augoustides
Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass.
February 2022, The Eurasian journal of medicine,
John G T Augoustides
Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass.
July 2021, Journal of endocrinological investigation,
John G T Augoustides
Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series.
August 2018, A&A practice,
John G T Augoustides
Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?
June 2003, The Journal of thoracic and cardiovascular surgery,
John G T Augoustides
Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass.
March 2004, The Journal of thoracic and cardiovascular surgery,
John G T Augoustides
Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies.
January 2020, SAGE open medicine,
John G T Augoustides
Induced mild hypothermia in post-cardiopulmonary bypass vasoplegia syndrome.
January 2009, Annals of cardiac anaesthesia,
John G T Augoustides
Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
October 2020, Journal of cardiothoracic and vascular anesthesia,
John G T Augoustides
Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation.
January 2018, ASAIO journal (American Society for Artificial Internal Organs : 1992),
John G T Augoustides
Plasma Renin Activity Increases With Cardiopulmonary Bypass and is Associated With Vasoplegia After Cardiac Surgery.
March 2023, Journal of cardiothoracic and vascular anesthesia,
Copied contents to your clipboard!